Keywords: nimh, study, says, older, antipsycotics, cheaper, effective
NIMH study says older antipsycotics are cheaper and as effective as 2nd-gen drugs
Article | 11 December 2006
A US National Institutes of Health-funded project, the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE), concluded that the older, first-generation ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
